Arrowhead Pharmaceuticals

Pharma

With EU backing, Sanofi gains long-awaited win for tolebrutinib

Sanofi has scored a win for troubled tolebrutinib as the CHMP has recommended its approval for patients with secondary progressive multiple sclerosis.

Kevin Dunleavy Apr 24, 2026 11:30am

Ionis slashes Tryngolza's price ahead of planned label expansion

Mar 25, 2026 2:59pm

Arrowhead strikes true with first FDA approval

Nov 18, 2025 3:44pm

Three blocks displaying from left to right a person a handshake and another person

Ionis, Arrowhead sponsor new triglyceride education group

Mar 28, 2025 10:10am

Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025

Feb 28, 2025 10:18am

Arrowhead targets rare disease patients with awareness campaign

Nov 5, 2024 11:58am